This report provides comprehensive information on the current therapeutic developmental pipeline of Archer Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope The report provides brief overview of Archer Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Archer Pharmaceuticals, Inc.s human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Archer Pharmaceuticals, Inc.s pipeline products Reasons to buy Evaluate Archer Pharmaceuticals, Inc.s strategic position with total access to detailed information on its product pipeline Assess the growth potential of Archer Pharmaceuticals, Inc. in its therapy areas of focus Identify new drug targets and therapeutic classes in the Archer Pharmaceuticals, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of Archer Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities

1. Archer Pharmaceuticals Inc - Product Pipeline Review - 2015
Global Markets Directs, Archer Pharmaceuticals, Inc. Product Pipeline Review 2015, provides an overview of the Archer Pharmaceuticals, Inc.s pharmaceutical
research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Archer Pharmaceuticals, Inc.s, complete with comparative
analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews
latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides brief overview of Archer Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Archer Pharmaceuticals, Inc.s human therapeutic division and enlists all their major and minor projects The report features
product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special
feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement
Latest news and deals relating to the Archer Pharmaceuticals, Inc.s pipeline products Reasons to buy
Evaluate Archer Pharmaceuticals, Inc.s strategic position with total access to detailed information on its product pipeline Assess the growth potential of Archer
Pharmaceuticals, Inc. in its therapy areas of focus Identify new drug targets and therapeutic classes in the Archer Pharmaceuticals, Inc.s R&D portfolio and
develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Archer Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities Identify
emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions
effectively by identifying the most promising pipeline of Archer Pharmaceuticals, Inc. Develop and design in-licensing and out-licensing strategies by identifying
prospective partners with the most attractive projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of
Archer Pharmaceuticals, Inc. and identify potential opportunities in those areas Avoid Intellectual Property Rights related issues
table Of Contents
table Of Contents 2
list Of Tables 3
list Of Figures 3
archer Pharmaceuticals, Inc. Snapshot 4
archer Pharmaceuticals, Inc. Overview 4
key Information 4
key Facts 4
archer Pharmaceuticals, Inc. - Research And Development Overview 5
key Therapeutic Areas 5
archer Pharmaceuticals, Inc. - Pipeline Review 7
pipeline Products By Stage Of Development 7
pipeline Products - Monotherapy 8
archer Pharmaceuticals, Inc. - Pipeline Products Glance 9
archer Pharmaceuticals, Inc. - Late Stage Pipeline Products 9
phase Iii Products/combination Treatment Modalities 9
archer Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 10
phase I Products/combination Treatment Modalities 10
archer Pharmaceuticals, Inc. - Early Stage Pipeline Products 11
preclinical Products/combination Treatment Modalities 11
archer Pharmaceuticals, Inc. - Drug Profiles 12
nilvadipine 12
product Description 12
mechanism Of Action 12
r&d Progress 12
arc-031 14
product Description 14
mechanism Of Action 14
r&d Progress 14
arc-050 15
product Description 15
mechanism Of Action 15
r&d Progress 15
arc-069 16
Archer Pharmaceuticals Inc - Product Pipeline Review - 2015

2. product Description 16
mechanism Of Action 16
r&d Progress 16
archer Pharmaceuticals, Inc. - Pipeline Analysis 17
archer Pharmaceuticals, Inc. - Pipeline Products By Target 17
archer Pharmaceuticals, Inc. - Pipeline Products By Molecule Type 18
archer Pharmaceuticals, Inc. - Pipeline Products By Mechanism Of Action 19
archer Pharmaceuticals, Inc. - Recent Pipeline Updates 20
archer Pharmaceuticals, Inc. - Dormant Projects 21
archer Pharmaceuticals, Inc. - Locations And Subsidiaries 22
head Office 22
appendix 23
methodology 23
coverage 23
secondary Research 23
primary Research 23
expert Panel Validation 23
contact Us 23
disclaimer 24
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Archer Pharmaceuticals Inc - Product Pipeline Review - 2015